Skip to main content
Linde India Limited logo

Linde India Limited — Investor Relations & Filings

Ticker · LINDEINDIA ISIN · INE473A01011 LEI · 549300I8YN6PVG2KEU64 BSE.NS Manufacturing
Open in API
Filings indexed 692 across all filing types
Latest filing 2023-05-12 Regulatory Filings
Country IN India
Listing BSE.NS LINDEINDIA

About Linde India Limited

https://www.linde.in/

Linde India Limited specializes in the production and distribution of industrial, medical, and specialty gases. The company operates through two primary business segments: Gases and Engineering. The Gases segment provides a comprehensive portfolio including oxygen, nitrogen, argon, hydrogen, and various specialty gas mixtures tailored for diverse applications. The Engineering segment focuses on the design, manufacture, and installation of air separation units, cryogenic plants, and gas processing facilities. Serving sectors such as healthcare, steel, chemicals, and electronics, the company leverages advanced gas application technologies and an extensive distribution network. Its operations are characterized by a commitment to safety, operational excellence, and the delivery of high-purity gas solutions to meet complex industrial requirements.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter dated 12 May 2023 addressed to stock exchanges (NSE and BSE) informing about a scheduled Board Meeting on 23 May 2023. The purpose of the meeting is to consider and approve the Audited Annual Standalone and Consolidated Financial Results for the quarter and 15 months period ended 31 March 2023, and to recommend dividend if any. The document is a notification of an upcoming board meeting and financial results approval, not the actual financial results or report itself. The document length is short (1844 characters) and it does not contain any financial data or detailed report. It is an announcement complying with SEBI regulations about the board meeting and financial results approval. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Annual Report or Earnings Release.
2023-05-12 English
Loss of Share Certificates
Regulatory Filings
2023-04-26 English
Shareholders meeting
Regulatory Filings
2023-04-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-04-25 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-04-03 English
Change in Financial Year
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about a change in the company's financial year. It references an official order approving the change and mentions compliance with SEBI regulations. It also states that the company will submit audited financial results and audit reports for the extended financial year period by a future date. The document does not contain actual financial statements or detailed financial data; rather, it is an announcement of a regulatory change and upcoming report submission. The document length is short (2610 characters) and it serves as a formal notification to the exchanges and investors. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Annual Report (10-K) or Audit Report (AR).
2023-03-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.